{
    "code": "01027459",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01027459",
    "time": "2015-08-22 22:58:48",
    "許可證字號": "衛署藥製字第027459號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/11\/04",
    "發證日期": "72\/11\/04",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102745907",
    "中文品名": "敵乳素錠２．８７公絲（布克丁）",
    "英文品名": "DEPROLAC TABLETS 2.87MG (BROMOCRIPTINE) \"WEIDAR\"",
    "適應症": "乳漏症：產後原發性腫瘤藥物引起催乳素引起之月經失調及不孕症、抑制泌乳、原發性及腦炎後的帕金森氏病、產後乳腺炎、初期產後乳房充盈、催乳素引起之月經前症狀、催乳素有關之男性機能減退、陽萎及精子過少引起之不育症、催乳素分泌腺瘤、肢端肥大症",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "BROMOCRIPTINE MESILATE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1605609200  衛達化學製藥股份有限公司",
    "申請商地址": "台中市工業區２３路２１號",
    "主製造廠": {
        "製造廠名稱": "1605609300  衛達化學製藥股份有限公司",
        "製造廠廠址": "台中市工業區２３路２１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600000110",
            "成分名稱": "BROMOCRIPTINE MESILATE",
            "含量描述": "2.87",
            "含量": "2.8700000000",
            "單位": "MG"
        }
    ]
}